Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;21(1):91-101.
doi: 10.1007/s42000-021-00328-9. Epub 2021 Oct 30.

Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers

Erieta Kollari  1 , Ioanna Zografou  2 , Christos Sampanis  2 , Vasilios G Athyros  2 , Triantafyllos Didangelos  3 , Christos S Mantzoros  4 , Asterios Karagiannis  2
Affiliations

Serum adipokine levels in patients with type 1 diabetes are associated with degree of obesity but only resistin is independently associated with atherosclerosis markers

Erieta Kollari et al. Hormones (Athens). 2022 Mar.

Abstract

Purpose: The role of adipokines in causing inflammation and insulin resistance in normal weight and obese patients is generally well studied. However, there are often conflicting results regarding their levels in type 1 diabetes mellitus (T1DM) patients and their relationship to micro- and macrovascular disease. We therefore investigated which serum adipokine levels are independently associated with markers of early atherosclerosis and microvascular complications in patients with T1DM.

Methods: A cross-sectional study was performed in the Diabetes Outpatient Clinic of Hippokrateion General Hospital, Thessaloniki, Greece. Sixty T1DM patients (30 females, mean age 38.8 ± 10.6 years, mean diabetes duration 17.4 ± 9.9 years) were included. Plasma adiponectin, leptin, and resistin, carotid artery intima media thickness (cIMT), and arterial stiffness (pulse wave velocity, PWV/SpygmoCor CP System and Mobil-O-Graph 24 h PWA) were assessed.

Results: Leptin and resistin levels were significantly higher in overweight and obese patients (p = 0.002 and p = 0.039, respectively). Adiponectin was the only adipokine negatively correlated with BMI (rs = - 0.41, p = 0.001). We report a bivariate association between serum adiponectin levels and retinopathy (p = 0.007). Resistin was the only adipokine that showed significant correlation with systolic (rs = 0.42, p = 0.001) and diastolic (rs = 0.29, p = 0.024) hypertension and PWV (p = 0.035).

Conclusions: Serum adipokine levels demonstrate similar bivariate associations with anthropometric variables in patients with T1DM to those in normal weight subjects. Although microvascular complications are associated with serum adipokine levels by bivariate analysis, only resistin, an inflammatory marker, is independently associated with arterial stiffness in patients with T1DM.

Keywords: Adiponectin; Leptin; PWV; Resistin; cIMT.

PubMed Disclaimer

References

    1. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2014) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084–1094. https://doi.org/10.1016/S0140-6736(13)62219-9 - DOI - PubMed
    1. Minges KE, Whittemore R, Grey M (2013) Overweight and obesity in youth with type 1 diabetes. Annu Rev Nurs Res 31:47–69. https://doi.org/10.1891/0739-6686.31.47 - DOI - PubMed - PMC
    1. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group (2007) Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 30:2314–2320. https://doi.org/10.2337/dc06-2389 - DOI
    1. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667. https://doi.org/10.1007/s00125-004-1507-3 - DOI - PubMed
    1. Athyros V, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis D, Fiorino G, Rovida S, Correale C, Malesci A, Danese S (2009) Should adipokines be considered in the choice of the treatment of obesity-related health problems? Curr Drug Targets 11:122–135. https://doi.org/10.2174/138945010790030992 - DOI

LinkOut - more resources